Intercept
1 products tracked · names used in filings: Intercept
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Tue 17 Mar 2026🇺🇸 FDA approval
FDA approves Lynavoy (linerixibat), a new medicine
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Lynavoy linerixibat | Approved | 2026-03-17 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.